Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SERVE: Tadalafil for Systemic Right Ventricle
NCT03049540Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Oct 2017
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tadalafil in heart failure (HF), transposition of the great vessels (TGV), sponsored by Insel Gruppe. Started Oct 2017; status: completed.
02
Drugs
tadalafil
03
Conditions
heart failure (HF)transposition of the great vessels (TGV)
Beyond the preview
Go deeper on NCT03049540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03049540.